Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: February 12, 2026
Reporting Period: The filing announces financial results for the three months and full year ended December 31, 2025.
Key Financial Metrics
The provided text serves as a cover report referencing a press release (Exhibit 99.1) for detailed data. The filing text itself does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing text does not provide specific comparative data or material changes versus prior periods. It directs readers to the attached press release for historical information and results.
Guidance, Outlook, and Risks
- Forward-Looking Statements: The press release attached as Exhibit 99.1 contains forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from indicated projections.
- Cautionary Note: Investors are directed to the "Forward-Looking Statements" section of the press release for details on these risks.
- Legal Status: The information in this 8-K and Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated February 12, 2026) for specific revenue, earnings, and cash flow figures for Q4 and Full Year 2025.
- Examine the "Forward-Looking Statements" section in the press release for updated guidance and risk factors.
- Verify the trading status of Common Stock (BRKR) and 6.375% Mandatory Convertible Preferred Stock (BRKRP) on the Nasdaq Global Select Market.
- Confirm if any unusual items or contingencies were disclosed in the full press release text not summarized in this 8-K cover page.